Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Centre
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
Communication
In the News
Presentations
Contact Us
Contact Us
Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
18 Jan 2024
FDA Clearance Amplia's IND for Pancreatic Cancer Trial in US
17 Jan 2024
Amplia Reports First Patient Dosing In Phase 2a Accent Trial
02 Jan 2024
Change of Director's Interest Notice - Dr Warwick Tong
02 Jan 2024
Change of Director's Interest Notice - Dr Chris Burns
02 Jan 2024
Change of Director's Interest Notice - Dr Robert Peach
02 Jan 2024
Change of Director's Interest Notice - Jane Bell
02 Jan 2024
Notification of cessation of securities - ATX
02 Jan 2024
Application for quotation of securities - ATX
Previous
1
2
3
4
5
6
